Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy: End of One Size Fits All.

Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy: End of One Size Fits All. - 2019


English

0735-1097


*Breast Neoplasms
*Cardiotoxicity
Carvedilol
Humans
Lisinopril
Trastuzumab


MedStar Heart & Vascular Institute


Editorial

Powered by Koha